{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:21:09Z","timestamp":1778286069606,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tice.2024.102477","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T10:16:07Z","timestamp":1720952167000},"page":"102477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["ASF1B is an essential prognostic indicator linked to the growth and resistance characteristics of bladder cancer"],"prefix":"10.1016","volume":"89","author":[{"given":"Peng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yirong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.tice.2024.102477_bib1","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.7150\/jca.69544","article-title":"ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer","volume":"vol. 13","author":"Chen","year":"2022","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.tice.2024.102477_bib2","first-page":"749","article-title":"Bladder cancer: current challenges and future directions","volume":"vol. 57","author":"Dobruch","year":"2021","journal-title":"Med. (Kaunas., Lith. )"},{"issue":"7679","key":"10.1016\/j.tice.2024.102477_bib3","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/551S33a","article-title":"Bladder cancer","volume":"vol. 551","author":"Grayson","year":"2017","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.tice.2024.102477_bib4","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1002\/cam4.4203","article-title":"Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker","volume":"vol. 10","author":"Hu","year":"2021","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.tice.2024.102477_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbrc.2019.02.060","article-title":"Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma","volume":"vol. 511","author":"Jiangqiao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.tice.2024.102477_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3233\/CBM-210490","article-title":"Downregulation of ASF1B inhibits tumor progression and enhances efficacy of cisplatin in pancreatic cancer","volume":"vol. 34","author":"Kim","year":"2022","journal-title":"Cancer Biomark.\u00a0Sect. A Dis. Markers"},{"issue":"19","key":"10.1016\/j.tice.2024.102477_bib7","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"vol. 324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.tice.2024.102477_bib8","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2174\/1386207325666220820112111","article-title":"ASF1B, as an independent prognostic biomarker, correlates with immune infiltrates in hepatocellular carcinoma","volume":"vol. 26","author":"Li","year":"2023","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"10.1016\/j.tice.2024.102477_bib9","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"vol. 68","author":"Li","year":"2023","journal-title":"Drug Resist. Update.\u00a0Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"8","key":"10.1016\/j.tice.2024.102477_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41419-020-02872-5","article-title":"ASF1B promotes cervical cancer progression through stabilization of CDK9","volume":"vol. 11","author":"Liu","year":"2020","journal-title":"Cell death Dis."},{"issue":"8","key":"10.1016\/j.tice.2024.102477_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41419-020-02872-5","article-title":"ASF1B promotes cervical cancer progression through stabilization of CDK9","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.tice.2024.102477_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.medcli.2017.06.009","article-title":"Bladder cancer: present and future\u00a0\u201cTumor vesical: presente y futuro.\u201d","volume":"vol. 149","author":"Martinez","year":"2017","journal-title":"Med. Clin."},{"issue":"5","key":"10.1016\/j.tice.2024.102477_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/REP-15-0327","article-title":"Loss of the histone chaperone ASF1B reduces female reproductive capacity in mice","volume":"151","author":"Messiaen","year":"2016","journal-title":"Reproduction"},{"key":"10.1016\/j.tice.2024.102477_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.801506","article-title":"ASF1B serves as a potential therapeutic target by influencing cell cycle and proliferation in hepatocellular carcinoma","volume":"vol. 11","author":"Ouyang","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.tice.2024.102477_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MOU.0000000000000601","article-title":"Trimodality therapy for bladder cancer: modern management and future directions","volume":"vol. 29","author":"Pham","year":"2019","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.tice.2024.102477_bib16","article-title":"ASF1B: a possible prognostic marker, therapeutic target, and predictor of immunotherapy in male thyroid carcinoma","volume":"vol. 12","author":"Qiu","year":"2022","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.tice.2024.102477_bib17","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: an update","volume":"vol. 38","author":"Richters","year":"2020","journal-title":"World J. Urol."},{"issue":"11","key":"10.1016\/j.tice.2024.102477_bib18","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.21873\/anticanres.14629","article-title":"Oral recombinant methioninase sensitizes a bladder cancer orthotopic xenograft mouse model to low-dose cisplatinum and prevents metastasis","volume":"vol. 40","author":"Sun","year":"2020","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.tice.2024.102477_bib19","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s11010-022-04404-5","article-title":"Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer","volume":"vol. 477","author":"Wang","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tice.2024.102477_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.626663","article-title":"Construction of Novel lncRNA-miRNA-mRNA network associated with recurrence and identification of immune-related potential regulatory axis in hepatocellular carcinoma","volume":"vol. 11","author":"Zhan","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2024.102477_bib21","article-title":"ASF1B promotes oncogenesis in lung adenocarcinoma and other cancer types","volume":"vol. 11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.tice.2024.102477_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3892\/ol.2023.13828","article-title":"Knockdown of ASF1B inhibits cell proliferation, migration, invasion and cisplatin resistance in gastric cancer through the Myc pathway","volume":"vol. 25","author":"Zhang","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tice.2024.102477_bib23","article-title":"Increased ASF1B expression correlates with poor prognosis in patients with gliomas","volume":"vol. 12","author":"Zhu","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816624001782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816624001782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T22:01:22Z","timestamp":1725141682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816624001782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":23,"alternative-id":["S0040816624001782"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2024.102477","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ASF1B is an essential prognostic indicator linked to the growth and resistance characteristics of bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2024.102477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102477"}}